TG Therapeutics announces five-year BRIUMVI comparative analysis publication
The analysis compares BRIUMVI with ocrelizumab and ofatumumab in relapsing multiple sclerosis.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
2 results loaded, newest first. End of these results.
TG Therapeutics Announces Five-Year Comparative Analysis Publication
The publication compares BRIUMVI with ocrelizumab and ofatumumab in relapsing multiple sclerosis.